![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 21774 |
FusionGeneSummary for MFSD2A_LAPTM5 |
![]() |
Fusion gene information | Fusion gene name: MFSD2A_LAPTM5 | Fusion gene ID: 21774 | Hgene | Tgene | Gene symbol | MFSD2A | LAPTM5 | Gene ID | 84879 | 7805 |
Gene name | major facilitator superfamily domain containing 2A | lysosomal protein transmembrane 5 | |
Synonyms | MCPH15|MFSD2|NLS1 | CLAST6 | |
Cytomap | 1p34.2 | 1p35.2 | |
Type of gene | protein-coding | protein-coding | |
Description | sodium-dependent lysophosphatidylcholine symporter 1major facilitator superfamily domain-containing protein 2Asodium-dependent LPC symporter 1 | lysosomal-associated transmembrane protein 5CD40-ligand-activated specific transcriptshuman retinoic acid-inducible E3 proteinlysosomal associated multispanning membrane protein 5lysosomal multispanning membrane protein 5lysosomal-associated multitra | |
Modification date | 20180329 | 20180523 | |
UniProtAcc | Q8NA29 | Q13571 | |
Ensembl transtripts involved in fusion gene | ENST00000372811, ENST00000420632, ENST00000372809, ENST00000480630, | ENST00000294507, ENST00000476492, | |
Fusion gene scores | * DoF score | 4 X 4 X 3=48 | 3 X 1 X 4=12 |
# samples | 5 | 4 | |
** MAII score | log2(5/48*10)=0.0588936890535686 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(4/12*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: MFSD2A [Title/Abstract] AND LAPTM5 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation | Tumor suppressor gene involved fusion gene, in-frame but not retained their domain. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | MFSD2A | GO:0051977 | lysophospholipid transport | 24828044 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | LGG | TCGA-CS-6188-01A | MFSD2A | chr1 | 40421057 | + | LAPTM5 | chr1 | 31215396 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000372811 | ENST00000294507 | MFSD2A | chr1 | 40421057 | + | LAPTM5 | chr1 | 31215396 | - |
5CDS-5UTR | ENST00000372811 | ENST00000476492 | MFSD2A | chr1 | 40421057 | + | LAPTM5 | chr1 | 31215396 | - |
5UTR-3CDS | ENST00000420632 | ENST00000294507 | MFSD2A | chr1 | 40421057 | + | LAPTM5 | chr1 | 31215396 | - |
5UTR-5UTR | ENST00000420632 | ENST00000476492 | MFSD2A | chr1 | 40421057 | + | LAPTM5 | chr1 | 31215396 | - |
In-frame | ENST00000372809 | ENST00000294507 | MFSD2A | chr1 | 40421057 | + | LAPTM5 | chr1 | 31215396 | - |
5CDS-5UTR | ENST00000372809 | ENST00000476492 | MFSD2A | chr1 | 40421057 | + | LAPTM5 | chr1 | 31215396 | - |
intron-3CDS | ENST00000480630 | ENST00000294507 | MFSD2A | chr1 | 40421057 | + | LAPTM5 | chr1 | 31215396 | - |
intron-5UTR | ENST00000480630 | ENST00000476492 | MFSD2A | chr1 | 40421057 | + | LAPTM5 | chr1 | 31215396 | - |
Top |
FusionProtFeatures for MFSD2A_LAPTM5 |
![]() |
Hgene | Tgene |
MFSD2A | LAPTM5 |
Sodium-dependent lysophosphatidylcholine (LPC)symporter, which plays an essential role for blood-brain barrierformation and function (By similarity). Specifically expressed inendothelium of the blood-brain barrier of micro-vessels andtransports LPC into the brain (By similarity). Transport of LPC isessential because it constitutes the major mechanism by whichdocosahexaenoic acid (DHA), an omega-3 fatty acid that isessential for normal brain growth and cognitive function, entersthe brain (PubMed:26005868). Transports LPC carrying long-chainfatty acids such LPC oleate and LPC palmitate with a minimum acylchain length of 14 carbons (By similarity). Does not transportdocosahexaenoic acid in unesterified fatty acid (By similarity).Specifically required for blood-brain barrier formation andfunction, probably by mediating lipid transport (By similarity).Not required for central nervous system vascular morphogenesis (Bysimilarity). Acts as a transporter for tunicamycin, an inhibitorof asparagine-linked glycosylation (PubMed:21677192). In placenta,acts as a receptor for ERVFRD-1/syncytin-2 and is required fortrophoblast fusion (PubMed:18988732, PubMed:23177091).{ECO:0000250|UniProtKB:Q9DA75, ECO:0000269|PubMed:18988732,ECO:0000269|PubMed:21677192, ECO:0000269|PubMed:23177091,ECO:0000269|PubMed:26005868}. | May have a special functional role during embryogenesisand in adult hematopoietic cells. {ECO:0000269|PubMed:8661146}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | >LAPTM5 | chr1:40421057 | chr1:31215396 | ENST00000294507 | - | 0 | 8 | 246_258 | 29 | 263 | Compositional bias | Note=Pro-rich |
Tgene | >LAPTM5 | chr1:40421057 | chr1:31215396 | ENST00000294507 | - | 0 | 8 | 134_154 | 29 | 263 | Transmembrane | Helical |
Tgene | >LAPTM5 | chr1:40421057 | chr1:31215396 | ENST00000294507 | - | 0 | 8 | 184_204 | 29 | 263 | Transmembrane | Helical |
Tgene | >LAPTM5 | chr1:40421057 | chr1:31215396 | ENST00000294507 | - | 0 | 8 | 64_84 | 29 | 263 | Transmembrane | Helical |
Tgene | >LAPTM5 | chr1:40421057 | chr1:31215396 | ENST00000294507 | - | 0 | 8 | 92_112 | 29 | 263 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 35_38 | 31 | 544 | Compositional bias | Note=Poly-Lys |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 35_38 | 31 | 531 | Compositional bias | Note=Poly-Lys |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 102_128 | 31 | 544 | Topological domain | Extracellular |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 150_160 | 31 | 544 | Topological domain | Cytoplasmic |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 182_256 | 31 | 544 | Topological domain | Extracellular |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 1_46 | 31 | 544 | Topological domain | Extracellular |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 278_310 | 31 | 544 | Topological domain | Cytoplasmic |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 332_344 | 31 | 544 | Topological domain | Extracellular |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 366_370 | 31 | 544 | Topological domain | Cytoplasmic |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 392_393 | 31 | 544 | Topological domain | Extracellular |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 415_437 | 31 | 544 | Topological domain | Cytoplasmic |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 459_480 | 31 | 544 | Topological domain | Extracellular |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 502_543 | 31 | 544 | Topological domain | Cytoplasmic |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 68_80 | 31 | 544 | Topological domain | Cytoplasmic |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 102_128 | 31 | 531 | Topological domain | Extracellular |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 150_160 | 31 | 531 | Topological domain | Cytoplasmic |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 182_256 | 31 | 531 | Topological domain | Extracellular |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 1_46 | 31 | 531 | Topological domain | Extracellular |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 278_310 | 31 | 531 | Topological domain | Cytoplasmic |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 332_344 | 31 | 531 | Topological domain | Extracellular |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 366_370 | 31 | 531 | Topological domain | Cytoplasmic |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 392_393 | 31 | 531 | Topological domain | Extracellular |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 415_437 | 31 | 531 | Topological domain | Cytoplasmic |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 459_480 | 31 | 531 | Topological domain | Extracellular |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 502_543 | 31 | 531 | Topological domain | Cytoplasmic |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 68_80 | 31 | 531 | Topological domain | Cytoplasmic |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 129_149 | 31 | 544 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 161_181 | 31 | 544 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 257_277 | 31 | 544 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 311_331 | 31 | 544 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 345_365 | 31 | 544 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 371_391 | 31 | 544 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 394_414 | 31 | 544 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 438_458 | 31 | 544 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 47_67 | 31 | 544 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 481_501 | 31 | 544 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372809 | + | 1 | 14 | 81_101 | 31 | 544 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 129_149 | 31 | 531 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 161_181 | 31 | 531 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 257_277 | 31 | 531 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 311_331 | 31 | 531 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 345_365 | 31 | 531 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 371_391 | 31 | 531 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 394_414 | 31 | 531 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 438_458 | 31 | 531 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 47_67 | 31 | 531 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 481_501 | 31 | 531 | Transmembrane | Helical |
Hgene | >MFSD2A | chr1:40421057 | chr1:31215396 | ENST00000372811 | + | 1 | 14 | 81_101 | 31 | 531 | Transmembrane | Helical |
Tgene | LAPTM5 | chr1:40421057 | chr1:31215396 | ENST00000294507 | - | 0 | 8 | 19_39 | 29 | 263 | Transmembrane | Helical |
Top |
FusionGeneSequence for MFSD2A_LAPTM5 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_MFSD2A_ENST00000372811_chr1_40421057_+_LAPTM5_ENST00000294507_chr1_31215396_-_265aa MAKGEGAESGSAAGLLPTSILQSTERPAQVKIMSVLLFIEHSVEVAHGKASCKLSQMGYLRIADLISSFLLITMLFIISLSLLIGVVKNR EKYLLPFLSLQIMDYLLCLLTLLGSYIELPAYLKLASRSRASSSKFPLMTLQLLDFCLSILTLCSSYMEVPTYLNFKSMNHMNYLPSQED >In-frame_MFSD2A_ENST00000372809_chr1_40421057_+_LAPTM5_ENST00000294507_chr1_31215396_-_265aa MAKGEGAESGSAAGLLPTSILQSTERPAQVKIMSVLLFIEHSVEVAHGKASCKLSQMGYLRIADLISSFLLITMLFIISLSLLIGVVKNR EKYLLPFLSLQIMDYLLCLLTLLGSYIELPAYLKLASRSRASSSKFPLMTLQLLDFCLSILTLCSSYMEVPTYLNFKSMNHMNYLPSQED |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_MFSD2A_ENST00000372811_chr1_40421057_+_LAPTM5_ENST00000294507_chr1_31215396_-_795nt ATGGCCAAAGGAGAAGGCGCCGAGAGCGGCTCCGCGGCGGGGCTGCTACCCACCAGCATCCTCCAAAGCACTGAACGCCCGGCCCAGGTG AAGATCATGAGCGTCTTGTTGTTCATCGAGCACTCAGTAGAGGTGGCCCATGGCAAGGCGTCCTGCAAGCTCTCCCAGATGGGCTACCTC AGGATCGCTGACCTGATCTCCAGCTTCCTGCTCATCACCATGCTCTTCATCATCAGCCTGAGCCTACTGATCGGCGTAGTCAAGAACCGG GAGAAGTACCTGCTGCCCTTCCTGTCCCTGCAAATCATGGACTATCTCCTGTGCCTGCTCACCCTGCTGGGCTCCTACATTGAGCTGCCC GCCTACCTCAAGTTGGCCTCCCGGAGCCGTGCTAGCTCCTCCAAGTTCCCCCTGATGACGCTGCAGCTGCTGGACTTCTGCCTGAGCATC CTGACCCTCTGCAGCTCCTACATGGAAGTGCCCACCTATCTCAACTTCAAGTCCATGAACCACATGAATTACCTCCCCAGCCAGGAGGAT ATGCCTCATAACCAGTTCATCAAGATGATGATCATCTTTTCCATCGCCTTCATCACTGTCCTTATCTTCAAGGTCTACATGTTCAAGTGC GTGTGGCGGTGCTACAGATTGATCAAGTGCATGAACTCGGTGGAGGAGAAGAGAAACTCCAAGATGCTCCAGAAGGTGGTCCTGCCGTCC >In-frame_MFSD2A_ENST00000372809_chr1_40421057_+_LAPTM5_ENST00000294507_chr1_31215396_-_795nt ATGGCCAAAGGAGAAGGCGCCGAGAGCGGCTCCGCGGCGGGGCTGCTACCCACCAGCATCCTCCAAAGCACTGAACGCCCGGCCCAGGTG AAGATCATGAGCGTCTTGTTGTTCATCGAGCACTCAGTAGAGGTGGCCCATGGCAAGGCGTCCTGCAAGCTCTCCCAGATGGGCTACCTC AGGATCGCTGACCTGATCTCCAGCTTCCTGCTCATCACCATGCTCTTCATCATCAGCCTGAGCCTACTGATCGGCGTAGTCAAGAACCGG GAGAAGTACCTGCTGCCCTTCCTGTCCCTGCAAATCATGGACTATCTCCTGTGCCTGCTCACCCTGCTGGGCTCCTACATTGAGCTGCCC GCCTACCTCAAGTTGGCCTCCCGGAGCCGTGCTAGCTCCTCCAAGTTCCCCCTGATGACGCTGCAGCTGCTGGACTTCTGCCTGAGCATC CTGACCCTCTGCAGCTCCTACATGGAAGTGCCCACCTATCTCAACTTCAAGTCCATGAACCACATGAATTACCTCCCCAGCCAGGAGGAT ATGCCTCATAACCAGTTCATCAAGATGATGATCATCTTTTCCATCGCCTTCATCACTGTCCTTATCTTCAAGGTCTACATGTTCAAGTGC GTGTGGCGGTGCTACAGATTGATCAAGTGCATGAACTCGGTGGAGGAGAAGAGAAACTCCAAGATGCTCCAGAAGGTGGTCCTGCCGTCC |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_MFSD2A_ENST00000372811_chr1_40421057_+_LAPTM5_ENST00000294507_chr1_31215396_-_2317nt GAGGGGGCGTGCAGCAGAGTGCGTTCCTCGTCTGCCAGCCGGCTTGGCTAGCGCGCGGCGGCCGTGGCTAAGGCTGCTACGAAGCGAGCT TGGGAGGAGCAGCGGCCTGCGGGGCAGAGGAGCATCCCGTCTACCAGGTCCCAAGCGGCGTGGCCCGCGGGTCATGGCCAAAGGAGAAGG CGCCGAGAGCGGCTCCGCGGCGGGGCTGCTACCCACCAGCATCCTCCAAAGCACTGAACGCCCGGCCCAGGTGAAGATCATGAGCGTCTT GTTGTTCATCGAGCACTCAGTAGAGGTGGCCCATGGCAAGGCGTCCTGCAAGCTCTCCCAGATGGGCTACCTCAGGATCGCTGACCTGAT CTCCAGCTTCCTGCTCATCACCATGCTCTTCATCATCAGCCTGAGCCTACTGATCGGCGTAGTCAAGAACCGGGAGAAGTACCTGCTGCC CTTCCTGTCCCTGCAAATCATGGACTATCTCCTGTGCCTGCTCACCCTGCTGGGCTCCTACATTGAGCTGCCCGCCTACCTCAAGTTGGC CTCCCGGAGCCGTGCTAGCTCCTCCAAGTTCCCCCTGATGACGCTGCAGCTGCTGGACTTCTGCCTGAGCATCCTGACCCTCTGCAGCTC CTACATGGAAGTGCCCACCTATCTCAACTTCAAGTCCATGAACCACATGAATTACCTCCCCAGCCAGGAGGATATGCCTCATAACCAGTT CATCAAGATGATGATCATCTTTTCCATCGCCTTCATCACTGTCCTTATCTTCAAGGTCTACATGTTCAAGTGCGTGTGGCGGTGCTACAG ATTGATCAAGTGCATGAACTCGGTGGAGGAGAAGAGAAACTCCAAGATGCTCCAGAAGGTGGTCCTGCCGTCCTACGAGGAAGCCCTGTC TTTGCCATCGAAGACCCCAGAGGGGGGCCCAGCACCACCCCCATACTCAGAGGTGTGACCCTCGCCAGGCCCCAGCCCCAGTGCTGGGAG GGGTGGAGCTGCCTCATAATCTGCTTTTTTGCTTTGGTGGCCCCTGTGGCCTGGGTGGGCCCTCCCGCCCCTCCCTGGCAGGACAATCTG CTTGTGTCTCCCTCGCTGGCCTGCTCCTCCTGCAGGGCCTGTGAGCTGCTCACAACTGGGTCAACGCTTTAGGCTGAGTCACTCCTCGGG TCTCTCCATAATTCAGCCCAACAATGCTTGGTTTATTTCAATCAGCTCTGACACTTGTTTAGACGATTGGCCATTCTAAAGTTGGTGAGT TTGTCAAGCAACTATCGACTTGATCAGTTCAGCCAAGCAACTGACAAATCAAAAACCCACTTGTCAGTTCAGTAAAATAATTTGGTCAAA CAACAGTCTATTGCATTGATTTATAAATAGTTGTCAGTTCACATAGCAATTTAATCAAGTAATCATTAATTAGTTACCCCCTATATATAA ATATATGTAATCAATTTCTTCAAATAGCTTGCTTACATGATAATCAATTAGCCAACCATGAGTCATTTAGAATAGTGATAAATAGAATAC ACAGAATAGTGATGAAATTCAATTTAAAAAATCACGTTAGCCTCCAAACCATTTAATTCAAATGAACCCATCAACTGGATGCCAACTCTG GCGAATGTAGGACCTCTGAGTGGCTGTATAATTGTTAATTCAAATGAAATTCATTTAAACAGTTGACAAACTGTCATTCAACAATTAGCT CCAGGAAATAACAGTTATTTCATCATAAAACAGTCCCTTCAAACACACAATTGTTCTGCTGAAGAGTTGTCATCAACAATCCAATGCTCA CCTATTCAGTTGCTCTGTGGTCAGTGTGGCTGCATAACAGTGGATTCCATGAAAGGAGTCATTTTAGTGATGAGCTGCCAGTCCATTCCC AGGCCAGGCTGTCGCTGGCCATCCATTCAGTCGATTCAGTCATAGGCGAATCTGTTCTGCCCGAGGCTTGTGGTCAAGCAAAAATTCAGC CCTGAAATCAGGCACATCTGTTCGTTGGACTAAACCCACAGGTTAGTTCAGTCAAAGCAGGCAACCCCCTTGTGGGCACTGACCCTGCCA CTGGGGTCATGGCGGTTGTGGCAGCTGGGGAGGTTTGGCCCCAACAGCCCTCCTGTGCCTGCTTCCCTGTGTGTCGGGGTCCTCCAGGGA GCTGACCCAGAGGTGGAGGCCACGGAGGCAGGGTCTCTGGGGACTGTCGGGGGGTACAGAGGGAGAAGGCTCTGCAAGAGCTCCCTGGCA >In-frame_MFSD2A_ENST00000372809_chr1_40421057_+_LAPTM5_ENST00000294507_chr1_31215396_-_2297nt GCGTTCCTCGTCTGCCAGCCGGCTTGGCTAGCGCGCGGCGGCCGTGGCTAAGGCTGCTACGAAGCGAGCTTGGGAGGAGCAGCGGCCTGC GGGGCAGAGGAGCATCCCGTCTACCAGGTCCCAAGCGGCGTGGCCCGCGGGTCATGGCCAAAGGAGAAGGCGCCGAGAGCGGCTCCGCGG CGGGGCTGCTACCCACCAGCATCCTCCAAAGCACTGAACGCCCGGCCCAGGTGAAGATCATGAGCGTCTTGTTGTTCATCGAGCACTCAG TAGAGGTGGCCCATGGCAAGGCGTCCTGCAAGCTCTCCCAGATGGGCTACCTCAGGATCGCTGACCTGATCTCCAGCTTCCTGCTCATCA CCATGCTCTTCATCATCAGCCTGAGCCTACTGATCGGCGTAGTCAAGAACCGGGAGAAGTACCTGCTGCCCTTCCTGTCCCTGCAAATCA TGGACTATCTCCTGTGCCTGCTCACCCTGCTGGGCTCCTACATTGAGCTGCCCGCCTACCTCAAGTTGGCCTCCCGGAGCCGTGCTAGCT CCTCCAAGTTCCCCCTGATGACGCTGCAGCTGCTGGACTTCTGCCTGAGCATCCTGACCCTCTGCAGCTCCTACATGGAAGTGCCCACCT ATCTCAACTTCAAGTCCATGAACCACATGAATTACCTCCCCAGCCAGGAGGATATGCCTCATAACCAGTTCATCAAGATGATGATCATCT TTTCCATCGCCTTCATCACTGTCCTTATCTTCAAGGTCTACATGTTCAAGTGCGTGTGGCGGTGCTACAGATTGATCAAGTGCATGAACT CGGTGGAGGAGAAGAGAAACTCCAAGATGCTCCAGAAGGTGGTCCTGCCGTCCTACGAGGAAGCCCTGTCTTTGCCATCGAAGACCCCAG AGGGGGGCCCAGCACCACCCCCATACTCAGAGGTGTGACCCTCGCCAGGCCCCAGCCCCAGTGCTGGGAGGGGTGGAGCTGCCTCATAAT CTGCTTTTTTGCTTTGGTGGCCCCTGTGGCCTGGGTGGGCCCTCCCGCCCCTCCCTGGCAGGACAATCTGCTTGTGTCTCCCTCGCTGGC CTGCTCCTCCTGCAGGGCCTGTGAGCTGCTCACAACTGGGTCAACGCTTTAGGCTGAGTCACTCCTCGGGTCTCTCCATAATTCAGCCCA ACAATGCTTGGTTTATTTCAATCAGCTCTGACACTTGTTTAGACGATTGGCCATTCTAAAGTTGGTGAGTTTGTCAAGCAACTATCGACT TGATCAGTTCAGCCAAGCAACTGACAAATCAAAAACCCACTTGTCAGTTCAGTAAAATAATTTGGTCAAACAACAGTCTATTGCATTGAT TTATAAATAGTTGTCAGTTCACATAGCAATTTAATCAAGTAATCATTAATTAGTTACCCCCTATATATAAATATATGTAATCAATTTCTT CAAATAGCTTGCTTACATGATAATCAATTAGCCAACCATGAGTCATTTAGAATAGTGATAAATAGAATACACAGAATAGTGATGAAATTC AATTTAAAAAATCACGTTAGCCTCCAAACCATTTAATTCAAATGAACCCATCAACTGGATGCCAACTCTGGCGAATGTAGGACCTCTGAG TGGCTGTATAATTGTTAATTCAAATGAAATTCATTTAAACAGTTGACAAACTGTCATTCAACAATTAGCTCCAGGAAATAACAGTTATTT CATCATAAAACAGTCCCTTCAAACACACAATTGTTCTGCTGAAGAGTTGTCATCAACAATCCAATGCTCACCTATTCAGTTGCTCTGTGG TCAGTGTGGCTGCATAACAGTGGATTCCATGAAAGGAGTCATTTTAGTGATGAGCTGCCAGTCCATTCCCAGGCCAGGCTGTCGCTGGCC ATCCATTCAGTCGATTCAGTCATAGGCGAATCTGTTCTGCCCGAGGCTTGTGGTCAAGCAAAAATTCAGCCCTGAAATCAGGCACATCTG TTCGTTGGACTAAACCCACAGGTTAGTTCAGTCAAAGCAGGCAACCCCCTTGTGGGCACTGACCCTGCCACTGGGGTCATGGCGGTTGTG GCAGCTGGGGAGGTTTGGCCCCAACAGCCCTCCTGTGCCTGCTTCCCTGTGTGTCGGGGTCCTCCAGGGAGCTGACCCAGAGGTGGAGGC CACGGAGGCAGGGTCTCTGGGGACTGTCGGGGGGTACAGAGGGAGAAGGCTCTGCAAGAGCTCCCTGGCAATACCCCCTTGTGTAATTGC |
Top |
FusionGenePPI for MFSD2A_LAPTM5 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
MFSD2A | LAPTM5 | NEDD4, UBC, GGA3, ITCH, LAMP1, TNFAIP3, EPS15, UBA52, RNF168, ANKRD13A, TOM1L2, USP13, DCUN1D1, NEDD4L, WWP1, EPN3, SMURF2, HEYL, HEY1, EPN1, BAG3, DISP1, LDLRAD1, TP53 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for MFSD2A_LAPTM5 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for MFSD2A_LAPTM5 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | MFSD2A | C0025958 | Microcephaly | 2 | CTD_human |
Hgene | MFSD2A | C4225310 | MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE | 2 | UNIPROT |
Hgene | MFSD2A | C0037822 | Speech Disorders | 1 | CTD_human |
Hgene | MFSD2A | C3714756 | Intellectual Disability | 1 | CTD_human |
Tgene | LAPTM5 | C0017661 | IGA Glomerulonephritis | 1 | CTD_human |
Tgene | LAPTM5 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |